Skip to main content

MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

28 Apr 2025 Evaluate
Oxygenta Pharmaceutical has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manoj Sunil Chawda.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1768.45
Dr. Reddys Labs. 1355.70
Cipla 1378.50
Lupin 2002.85
Zydus Lifesciences 1233.70
View more..